The Consequences of Price Controls for Patients
2021 could be a bad year for patients in the United States. Lawmakers have resumed their fight to pass sweeping price...
2021 could be a bad year for patients in the United States. Lawmakers have resumed their fight to pass sweeping price...
Gerard Scimeca – CASE September 14, 2020 In the ongoing debate on the best way Washington can help lower...
Gerard Scimeca – Chairman, CASE April 16, 2020 In news that should surprise absolutely nobody, America’s healthcare professionals have...
December 5, 2019 Click Here to see full coalition letter. Text of Letter: We represent fiscal conservatives and free...
This month, millions of seniors will take advantage of the Medicare open enrollment period, shopping for Medicare Advantage and Medicare...
Gerard Scimeca – Chairman, CASE October 8, 2019 There is an impulse among some lawmakers that whatever the problem, more...
September 19, 2019 (Arlington, Virginia) — Today, CASE Vice President Gerard Scimeca issued a statement, condemning Speaker of the...
September 12, 2019 Earlier this week, a draft of Speaker of the House Nancy Pelosi’s drug pricing plan was leaked...
July 8, 2019 43 million seniors in the United States rely on Medicare Part D to provide them with the...
July 1 2019 Last week’s Democratic primary debates were full of meaningful, substantive and inspired policy solutions. Just kidding. Last...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers